Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleDuvelisib, an oral dual PI3K‐δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.AuthorsO'Brien, Susan; Patel, Manish; Kahl, Brad S.; Horwitz, Steven M.; Foss, Francine M.; Porcu, Pierluigi; Jones, Jeffrey; Burger, Jan; Jain, Nitin; Allen, Kerstin; Faia, Kerrie; Douglas, Mark; Stern, Howard M.; Sweeney, Jennifer; Kelly, Patrick; Kelly, Virginia; Flinn, IanPublicationAmerican Journal of Hematology, 2018, Vol 93, Issue 11, p1318ISSN0361-8609Publication typeArticleDOI10.1002/ajh.25243